204 related articles for article (PubMed ID: 25560459)
1. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
[TBL] [Abstract][Full Text] [Related]
2. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
3. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
[TBL] [Abstract][Full Text] [Related]
4. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
[TBL] [Abstract][Full Text] [Related]
5. Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway.
Yang CM; Lu YL; Chen HY; Hu ML
J Nutr Biochem; 2012 Sep; 23(9):1155-62. PubMed ID: 22137263
[TBL] [Abstract][Full Text] [Related]
6. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells.
Chuu CP; Chen RY; Hiipakka RA; Kokontis JM; Warner KV; Xiang J; Liao S
Biochem Biophys Res Commun; 2007 Jun; 357(2):341-6. PubMed ID: 17416342
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist.
Chuu CP; Hiipakka RA; Kokontis JM; Fukuchi J; Chen RY; Liao S
Cancer Res; 2006 Jul; 66(13):6482-6. PubMed ID: 16818617
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
Chonlaket P; Wongwan T; Soodvilai S
Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
[TBL] [Abstract][Full Text] [Related]
10. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
11. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
13. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous activation of the liver X receptors (LXRα and LXRβ) drives murine collagen-induced arthritis disease pathology.
Asquith DL; Miller AM; Reilly J; Kerr S; Welsh P; Sattar N; McInnes IB
Ann Rheum Dis; 2011 Dec; 70(12):2225-8. PubMed ID: 21859686
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells.
Soodvilai S; Jia Z; Fongsupa S; Chatsudthipong V; Yang T
Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1610-6. PubMed ID: 23077096
[TBL] [Abstract][Full Text] [Related]
16. Differential Role of Liver X Receptor (LXR)
Hansmann E; Mennillo E; Yoda E; Verreault M; Barbier O; Chen S; Tukey RH
Drug Metab Dispos; 2020 Apr; 48(4):255-263. PubMed ID: 31980500
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.
Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M
Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671
[TBL] [Abstract][Full Text] [Related]
19. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol efflux is LXRα isoform-dependent in human macrophages.
Ma AZ; Song ZY; Zhang Q
BMC Cardiovasc Disord; 2014 Jul; 14():80. PubMed ID: 24996838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]